Clarient Diagnostics has licensed cancer biomarker; NASA-sponsored bone test could spot osteoporosis and cancer;

> Arterial spin labeling (ASL) MRI, which measures cerebral blood flow, could act as a biomarker in Alzheimer's disease. Abstract

> GE Healthcare ($GE) company Clarient Diagnostic Services has licensed a genetic test for the cancer biomarker ALK (anaplastic lymphoma kinase) from Insight Genetics. Press release

> Israeli researchers have found American Indians with Jewish genetic markers; a group of Indians from the state of Colorado have the "Ashkenazi mutation" on the BRCA1 gene. News

> DNA methylation detected in the blood is linked with breast cancer. Abstract

> A NASA-sponsored bone biomarker test could spot osteoporosis and cancer. Story

> Quest Diagnostics has launched a test panel to help to detect thyroid cancer. Press release

> An immune system biomarker may be able to predict early death. Article

> Genetic mutation predicts heart disease. Report

> Protein phosphatase 4 levels correlate with poor prognosis in patients with stage II pancreatic ductal adenocarcinoma. Abstract

And Finally… New York University College of Dentistry has got a share of a $20.7 million NIH grant to find biomarkers for fighting periodontal disease. Press release

Suggested Articles

BD will begin working with Babson Diagnostics to help bring its lab-quality device for collecting blood from capillaries into retail pharmacies.

The former CEO of the molecular testing company Foundation Medicine, Troy Cox, has been named chairman of the Swiss big data firm Sophia Genetics.

Researchers at MIT used a machine-learning algorithm to uncover the potent antibiotic properties hiding within an old small-molecule candidate.